We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Invitro Maturation of Oocytes for Patients With Polycystic Ovaries

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00631982
Recruitment Status : Unknown
Verified March 2008 by Assaf-Harofeh Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : March 10, 2008
Last Update Posted : March 10, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
In vitro maturation of oocytes after minimal gonadotropin stimulation in patients with polycystic ovaries, to prevent cases of ovarian hyperstimulation.

Condition or disease Intervention/treatment
Infertility Polycystic Ovaries Procedure: in vitro matuartion of oocytes

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: In Vitro Maturation of Oocytes for Patients With Polycystic Ovaries
Study Start Date : April 2008
Estimated Primary Completion Date : October 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Group I
patients with PCO undergoing in vitro maturation and subsequently IVF and embryo transfer
Procedure: in vitro matuartion of oocytes
in vitro maturation of (immature) oocytes


Outcome Measures

Primary Outcome Measures :
  1. maturation rate, [ Time Frame: 18 months ]

Secondary Outcome Measures :
  1. Fertilization rate, pregnancy rate [ Time Frame: 18 months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 39 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Polycystic ovaries
  • Needing IVF for fertility treatment

Exclusion Criteria:

  • Age above 39
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00631982


Contacts
Contact: Raphael Ron - El, MD +972-8-9779005

Locations
Israel
IVF and Infertility Unit, Assaf Harofeh Medical Center Not yet recruiting
Zerifin, Israel, 70300
Contact: Raphael Ron-El, MD    +972-8-9779005      
Principal Investigator: Raphael Ron - El, MD         
Sponsors and Collaborators
Assaf-Harofeh Medical Center
More Information

Responsible Party: IVF and Infertility Unit, Assaf Harofeh Medical Center, Zerifin Israel, Assaf Harofeh Medical Center, Zerifin Israel
ClinicalTrials.gov Identifier: NCT00631982     History of Changes
Other Study ID Numbers: 22/08
First Posted: March 10, 2008    Key Record Dates
Last Update Posted: March 10, 2008
Last Verified: March 2008

Keywords provided by Assaf-Harofeh Medical Center:
in vitro maturation oocytes

Additional relevant MeSH terms:
Polycystic Ovary Syndrome
Infertility
Genital Diseases, Male
Genital Diseases, Female
Ovarian Cysts
Cysts
Neoplasms
Ovarian Diseases
Adnexal Diseases
Gonadal Disorders
Endocrine System Diseases